USA - NYSEARCA:SSY - US86737U1025 - Common Stock
The current stock price of SSY is 1.115 USD. In the past month the price decreased by -0.45%. In the past year, price increased by 32.74%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 18.29 | 110.69B | ||
| THC | TENET HEALTHCARE CORP | 13.06 | 17.91B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 10.93 | 14.46B | ||
| EHC | ENCOMPASS HEALTH CORP | 22.27 | 11.60B | ||
| ENSG | ENSIGN GROUP INC/THE | 29.26 | 10.54B | ||
| SGRY | SURGERY PARTNERS INC | 25.44 | 2.74B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 16.32 | 2.57B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 2.18B | ||
| ARDT | ARDENT HEALTH INC | 8.09 | 2.07B | ||
| NHC | NATIONAL HEALTHCARE CORP | 18.76 | 1.95B | ||
| PACS | PACS GROUP INC | 16.38 | 1.93B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 7.63 | 1.82B |
SunLink Health Systems, Inc. engages in the provision of healthcare products and services. The company is headquartered in Atlanta, Georgia. The Company’s operations are composed of a pharmacy business and an information technology (IT) business. The pharmacy business is composed of four operational areas conducted in three locations in southwest Louisiana: retail pharmacy products and services, consisting of retail pharmacy sales; institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to institutional clients or to patients in institutional settings, such as extended care and rehabilitation centers, behavioral and specialty hospitals, hospice, and correctional facilities and durable medical equipment products and services, consisting primarily of the sale and rental of products for institutional clients. Its subsidiary SunLink Health Systems Technology provides information technology (IT) services to outside customers.
SUNLINK HEALTH SYSTEMS INC
Suite 1120, 900 Circle 75 Parkway
Atlanta GEORGIA 30339 US
CEO: Robert M. Thornton Jr.
Employees: 1614
Phone: 17709337000
SunLink Health Systems, Inc. engages in the provision of healthcare products and services. The company is headquartered in Atlanta, Georgia. The Company’s operations are composed of a pharmacy business and an information technology (IT) business. The pharmacy business is composed of four operational areas conducted in three locations in southwest Louisiana: retail pharmacy products and services, consisting of retail pharmacy sales; institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to institutional clients or to patients in institutional settings, such as extended care and rehabilitation centers, behavioral and specialty hospitals, hospice, and correctional facilities and durable medical equipment products and services, consisting primarily of the sale and rental of products for institutional clients. Its subsidiary SunLink Health Systems Technology provides information technology (IT) services to outside customers.
The current stock price of SSY is 1.115 USD. The price increased by 16.15% in the last trading session.
SSY does not pay a dividend.
SSY has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
The next ex-dividend date for SUNLINK HEALTH SYSTEMS INC (SSY) is July 31, 2025.
SUNLINK HEALTH SYSTEMS INC (SSY) has a market capitalization of 7.85M USD. This makes SSY a Nano Cap stock.
ChartMill assigns a technical rating of 6 / 10 to SSY. When comparing the yearly performance of all stocks, SSY is one of the better performing stocks in the market, outperforming 87.81% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to SSY. SSY has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months SSY reported a non-GAAP Earnings per Share(EPS) of 0.26. The EPS increased by 125.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.55% | ||
| ROA | 9.87% | ||
| ROE | 12.86% | ||
| Debt/Equity | 0 |